{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:38:38Z","timestamp":1792539518129,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening","award":["8326200"],"award-info":[{"award-number":["8326200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer cells frequently alter iron metabolism by increasing uptake or decreasing export, promoting oncogenesis and proliferation. However, the quantitative relationship between iron homeostasis and cancer remains underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We simplified these alterations into measurable changes in the expression levels of iron transport-related genes. We investigated the expression of iron transport-related genes by comparing genomic data of 478 human cancer cell lines to 105 normal tissue samples, as well as analyzing clinically paired 6903 tumor to 709 normal samples. We revealed that cancer cells exhibited increased expression of transferrin receptor 1 (TFR1) or CD44 for iron uptake and decreased expression of ferroportin for iron efflux to favor iron accumulation. Using machine learning, we identified TFR1, CD44, and ferroportin as the top three features consistently associated most with patient survival. We developed a cancer-specific iron risk score (CIRS) using parametric time-to-event models based on RNA-seq data from TFR1, CD44, and ferroportin in 4723 patients spanning 15 cancers. The CIRS, cross-validated in five external datasets, significantly stratified survival risk for various cancers, and predicted chemotherapy response in two independent breast cancer pharmacogenomic datasets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study enhances the understanding of the relationship between iron homeostasis, survival, and chemotherapy response, laying the groundwork for iron-targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13040-026-00589-3","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:15:22Z","timestamp":1784888122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Iron homeostasis landscape informs patient survival and neoadjuvant chemotherapy response in cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaoqing","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangna","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu Steven","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"589_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.tips.2021.05.001","volume":"42","author":"K Roemhild","year":"2021","unstructured":"Roemhild K, von Maltzahn F, Weiskirchen R, Kn\u00fcchel R, von Stillfried S, Lammers T. Iron metabolism: pathophysiology and pharmacology. Trends Pharmacol Sci. 2021;42:640\u201356.","journal-title":"Trends Pharmacol Sci"},{"key":"589_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","volume":"38","author":"SV Torti","year":"2018","unstructured":"Torti SV, Manz DH, Paul BT, Blanchette-Farra N, Torti FM. Iron and Cancer. Annu Rev Nutr. 2018;38:97\u2013125.","journal-title":"Annu Rev Nutr"},{"key":"589_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00262-023-03625-x","volume":"73","author":"Y Luo","year":"2024","unstructured":"Luo Y, Liu C, Yao Y, Tang X, Yin E, Lu Z, et al. A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy. Cancer Immunol Immunother. 2024;73:37.","journal-title":"Cancer Immunol Immunother"},{"key":"589_CR4","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/jcp.29017","volume":"235","author":"S Zhang","year":"2020","unstructured":"Zhang S, Chang W, Wu H, Wang YH, Gong YW, Zhao YL, et al. Pan-cancer analysis of iron metabolic landscape across the Cancer Genome Atlas. J Cell Physiol. 2020;235:1013\u201324.","journal-title":"J Cell Physiol"},{"key":"589_CR5","doi-asserted-by":"crossref","unstructured":"Xu Q, Altrock E, Schmitt N, Streuer A, Rapp F, Nowak V, et al. In silico pan-cancer analysis reveals prognostic role of the erythroferrone (ERFE) gene in human malignancies. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms24021725"},{"key":"589_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10534-020-00243-3","volume":"33","author":"O Ibrahim","year":"2020","unstructured":"Ibrahim O, O\u2019Sullivan J. Iron chelators in cancer therapy. Biometals. 2020;33:201\u201315.","journal-title":"Biometals"},{"key":"589_CR7","doi-asserted-by":"crossref","unstructured":"Torti SV, Torti FM. Iron and cancer: 2020 vision. Cancer Res. 2020;80:5435\u201348.","DOI":"10.1158\/0008-5472.CAN-20-2017"},{"key":"589_CR8","doi-asserted-by":"publisher","unstructured":"Zhang DD. Ironing out the details of ferroptosis. Nat Cell Biol. 2024.26(9):1386\u201393. https:\/\/doi.org\/10.1038\/s41556-024-01361-7.","DOI":"10.1038\/s41556-024-01361-7"},{"key":"589_CR9","doi-asserted-by":"crossref","unstructured":"Gimeno M, Del Sada K, Rubio A. Precision oncology: a review to assess interpretability in several explainable methods. Brief Bioinform. 2023;24.","DOI":"10.1093\/bib\/bbad200"},{"key":"589_CR10","doi-asserted-by":"publisher","first-page":"e2207693","DOI":"10.1002\/advs.202207693","volume":"10","author":"H Kim","year":"2023","unstructured":"Kim H, Villareal LB, Liu Z, Haneef M, Falcon DM, Martin DR, et al. Transferrin Receptor-Mediated Iron Uptake Promotes Colon Tumorigenesis. Adv Sci (Weinh). 2023;10:e2207693.","journal-title":"Adv Sci (Weinh)"},{"key":"589_CR11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/psp4.12835","volume":"11","author":"Y Yao","year":"2022","unstructured":"Yao Y, Wang Z, Yong L, Yao Q, Tian X, Wang T, et al. Longitudinal and time-to-event modeling for prognostic implications of radical surgery in retroperitoneal sarcoma. CPT Pharmacometrics Syst Pharmacol. 2022;11:1170\u201382.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"589_CR12","doi-asserted-by":"publisher","first-page":"s1559","DOI":"10.3945\/ajcn.117.155804","volume":"106","author":"GJ Anderson","year":"2017","unstructured":"Anderson GJ, Frazer DM. Current understanding of iron homeostasis. Am J Clin Nutr. 2017;106:s1559\u201366.","journal-title":"Am J Clin Nutr"},{"key":"589_CR13","doi-asserted-by":"crossref","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, Kryukov GV, Lo CC, McDonald ER 3, et al. Next-generation characterization of the cancer cell line encyclopedia. Nature. 2019;569:503\u20138.","DOI":"10.1038\/s41586-019-1186-3"},{"key":"589_CR14","doi-asserted-by":"publisher","first-page":"D129","DOI":"10.1093\/nar\/gkab1030","volume":"50","author":"P Moreno","year":"2022","unstructured":"Moreno P, Fexova S, George N, Manning JR, Miao Z, Mohammed S, et al. Expression Atlas update: gene and protein expression in multiple species. Nucleic Acids Res. 2022;50:D129\u201340.","journal-title":"Nucleic Acids Res"},{"key":"589_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"key":"589_CR16","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1038\/s41467-024-46663-4","volume":"15","author":"RL Nielsen","year":"2024","unstructured":"Nielsen RL, Monfeuga T, Kitchen RR, Egerod L, Leal LG, Schreyer ATH, et al. Data-driven identification of predictive risk biomarkers for subgroups of osteoarthritis using interpretable machine learning. Nat Commun. 2024;15:2817.","journal-title":"Nat Commun"},{"key":"589_CR17","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.","journal-title":"Science"},{"key":"589_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/psp4.12319","volume":"7","author":"KM Jamsen","year":"2018","unstructured":"Jamsen KM, Patel K, Nieforth K, Kirkpatrick CMJ. A Regression Approach to Visual Predictive Checks for Population Pharmacometric Models. CPT Pharmacometrics Syst Pharmacol. 2018;7:678\u201386.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"589_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. Aaps j. 2011;13:143\u201351.","journal-title":"Aaps j"},{"key":"589_CR20","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/s41588-024-01853-0","volume":"56","author":"S Skerget","year":"2024","unstructured":"Skerget S, Penaherrera D, Chari A, Jagannath S, Siegel DS, Vij R, et al. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. Nat Genet. 2024;56:1878\u201389.","journal-title":"Nat Genet"},{"key":"589_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang KN, Wang Q, Li G, Zeng F, Zhang Y, et al. Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients. Genomics Proteom Bioinf. 2021;19:1\u201312.","journal-title":"Genomics Proteom Bioinf"},{"key":"589_CR22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","volume":"8","author":"J Ducie","year":"2017","unstructured":"Ducie J, Dao F, Considine M, Olvera N, Shaw PA, Kurman RJ, et al. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma. Nat Commun. 2017;8:990.","journal-title":"Nat Commun"},{"key":"589_CR23","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s41588-021-00920-0","volume":"53","author":"T Zhang","year":"2021","unstructured":"Zhang T, Joubert P, Ansari-Pour N, Zhao W, Hoang PH, Lokanga R, et al. Genomic and evolutionary classification of lung cancer in never smokers. Nat Genet. 2021;53:1348\u201359.","journal-title":"Nat Genet"},{"key":"589_CR24","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41586-024-07177-7","volume":"627","author":"J George","year":"2024","unstructured":"George J, Maas L, Abedpour N, Cartolano M, Kaiser L, Fischer RN, et al. Evolutionary trajectories of small cell lung cancer under therapy. Nature. 2024;627:880\u20139.","journal-title":"Nature"},{"key":"589_CR25","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1038\/s41467-020-19933-0","volume":"11","author":"YH Park","year":"2020","unstructured":"Park YH, Lal S, Lee JE, Choi YL, Wen J, Ram S, et al. Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome. Nat Commun. 2020;11:6175.","journal-title":"Nat Commun"},{"key":"589_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1470-2045(18)30111-6","volume":"19","author":"S Loibl","year":"2018","unstructured":"Loibl S, O\u2019Shaughnessy J, Untch M, Sikov WM, Rugo HS, McKee MD, et al. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. Lancet Oncol. 2018;19:497\u2013509.","journal-title":"Lancet Oncol"},{"key":"589_CR27","doi-asserted-by":"crossref","unstructured":"Wolf DM, Yau C, Wulfkuhle J, Brown-Swigart L, Gallagher RI, Lee PRE, et al. Redefining breast cancer subtypes to guide treatment prioritization and maximize response: predictive biomarkers across 10 cancer therapies. Cancer Cell. 2022;40:609\u201323.e6.","DOI":"10.1016\/j.ccell.2022.05.005"},{"key":"589_CR28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41557-020-0513-5","volume":"12","author":"S M\u00fcller","year":"2020","unstructured":"M\u00fcller S, Sindikubwabo F, Ca\u00f1eque T, Lafon A, Versini A, Lombard B, et al. CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat Chem. 2020;12:929\u201338.","journal-title":"Nat Chem"},{"key":"589_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.tips.2023.12.003","volume":"45","author":"YY Zhang","year":"2024","unstructured":"Zhang YY, Han Y, Li WN, Xu RH, Ju HQ. Tumor iron homeostasis and immune regulation. Trends Pharmacol Sci. 2024;45:145\u201356.","journal-title":"Trends Pharmacol Sci"},{"key":"589_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2018.07.009","volume":"53","author":"M El Hout","year":"2018","unstructured":"El Hout M, Dos Santos L, Hama\u00ef A, Mehrpour M. A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells. Semin Cancer Biol. 2018;53:125\u201338.","journal-title":"Semin Cancer Biol"},{"key":"589_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","volume":"25","author":"B Galy","year":"2024","unstructured":"Galy B, Conrad M, Muckenthaler M. Mechanisms controlling cellular and systemic iron homeostasis. Nat Rev Mol Cell Biol. 2024;25:133\u201355.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"589_CR32","first-page":"2929","volume":"5","author":"X Dai","year":"2015","unstructured":"Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J, et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res. 2015;5:2929\u201343.","journal-title":"Am J Cancer Res"},{"key":"589_CR33","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.7150\/thno.81847","volume":"13","author":"C Marvalim","year":"2023","unstructured":"Marvalim C, Datta A, Lee SC. Role of p53 in breast cancer progression: An insight into p53 targeted therapy. Theranostics. 2023;13:1421\u201342.","journal-title":"Theranostics"},{"key":"589_CR34","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1158\/1078-0432.CCR-19-0075","volume":"25","author":"L Dihge","year":"2019","unstructured":"Dihge L, Vallon-Christersson J, Hegardt C, Saal LH, H\u00e4kkinen J, Larsson C, et al. Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort. Clin Cancer Res. 2019;25:6368\u201381.","journal-title":"Clin Cancer Res"},{"key":"589_CR35","doi-asserted-by":"publisher","first-page":"100860","DOI":"10.1016\/j.mam.2020.100860","volume":"75","author":"SV Torti","year":"2020","unstructured":"Torti SV, Torti FM, Iron. The cancer connection. Mol Aspects Med. 2020;75:100860.","journal-title":"Mol Aspects Med"},{"key":"589_CR36","first-page":"916","volume":"8","author":"Y Shen","year":"2018","unstructured":"Shen Y, Li X, Dong D, Zhang B, Xue Y, Shang P. Transferrin receptor 1 in cancer: a new sight for cancer therapy. Am J Cancer Res. 2018;8:916\u201331.","journal-title":"Am J Cancer Res"},{"key":"589_CR37","doi-asserted-by":"publisher","first-page":"103772","DOI":"10.1016\/j.critrevonc.2022.103772","volume":"178","author":"M Abedi","year":"2022","unstructured":"Abedi M, Rahgozar S. Puzzling out iron complications in cancer drug resistance. Crit Rev Oncol Hematol. 2022;178:103772.","journal-title":"Crit Rev Oncol Hematol"},{"key":"589_CR38","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.7150\/thno.59092","volume":"11","author":"M Morales","year":"2021","unstructured":"Morales M, Xue X. Targeting iron metabolism in cancer therapy. Theranostics. 2021;11:8412\u201329.","journal-title":"Theranostics"},{"key":"589_CR39","doi-asserted-by":"publisher","first-page":"2541316","DOI":"10.1080\/07853890.2025.2541316","volume":"57","author":"Q Yuan","year":"2025","unstructured":"Yuan Q, Ye R, Qian Y, Yu H, Zhou Y, Cui X, et al. Machine learning and SHAP value interpretation for predicting the response to neoadjuvant chemotherapy and long-term clinical outcomes in Chinese female breast cancer. Ann Med. 2025;57:2541316.","journal-title":"Ann Med"},{"key":"589_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12964-020-00663-1","volume":"18","author":"B Tang","year":"2020","unstructured":"Tang B, Zhu J, Li J, Fan K, Gao Y, Cheng S, et al. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Commun Signal. 2020;18:174.","journal-title":"Cell Commun Signal"},{"key":"589_CR41","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3389\/fonc.2020.00788","volume":"10","author":"Y Mou","year":"2020","unstructured":"Mou Y, Zhang Y, Wu J, Hu B, Zhang C, Duan C, et al. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma. Front Oncol. 2020;10:788.","journal-title":"Front Oncol"},{"key":"589_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013;13:342\u201355.","journal-title":"Nat Rev Cancer"},{"key":"589_CR43","first-page":"4929","volume":"50","author":"A Donfrancesco","year":"1990","unstructured":"Donfrancesco A, Deb G, Dominici C, Pileggi D, Castello MA, Helson L. Effects of a single course of deferoxamine in neuroblastoma patients. Cancer Res. 1990;50:4929\u201330.","journal-title":"Cancer Res"},{"key":"589_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3109\/07357909709039731","volume":"15","author":"R Dreicer","year":"1997","unstructured":"Dreicer R, Kemp JD, Stegink LD, Cardillo T, Davis CS, Forest PK, et al. A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer. Cancer Invest. 1997;15:311\u20137.","journal-title":"Cancer Invest"},{"key":"589_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1056\/NEJMc1105726","volume":"365","author":"T Yamasaki","year":"2011","unstructured":"Yamasaki T, Terai S, Sakaida I. Deferoxamine for advanced hepatocellular carcinoma. N Engl J Med. 2011;365:576\u20138.","journal-title":"N Engl J Med"},{"key":"589_CR46","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1158\/2159-8290.CD-23-1194","volume":"13","author":"YR Murciano-Goroff","year":"2023","unstructured":"Murciano-Goroff YR, Suehnholz SP, Drilon A, Chakravarty D. Precision Oncology: 2023 in Review. Cancer Discov. 2023;13:2525\u201331.","journal-title":"Cancer Discov"},{"key":"589_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-024-01760-0","volume":"9","author":"XP Duan","year":"2024","unstructured":"Duan XP, Qin BD, Jiao XD, Liu K, Wang Z, Zang YS. New clinical trial design in precision medicine: discovery, development and direction. Signal Transduct Target Ther. 2024;9:57.","journal-title":"Signal Transduct Target Ther"},{"key":"589_CR48","doi-asserted-by":"publisher","first-page":"778492","DOI":"10.3389\/fonc.2021.778492","volume":"11","author":"Q Guo","year":"2021","unstructured":"Guo Q, Li L, Hou S, Yuan Z, Li C, Zhang W, et al. The Role of Iron in Cancer Progression. Front Oncol. 2021;11:778492.","journal-title":"Front Oncol"},{"key":"589_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/cpt.2049","volume":"109","author":"F Kluwe","year":"2021","unstructured":"Kluwe F, Michelet R, Mueller-Schoell A, Maier C, Klopp-Schulze L, van Dyk M, et al. Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations. Clin Pharmacol Ther. 2021;109:29\u201336.","journal-title":"Clin Pharmacol Ther"},{"key":"589_CR50","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/psp4.12937","volume":"12","author":"FW Ojara","year":"2023","unstructured":"Ojara FW, Henrich A, Frances N, Nassar YM, Huisinga W, Hartung N, et al. A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel\/platinum treated advanced non-small cell lung cancer patients. CPT Pharmacometrics Syst Pharmacol. 2023;12:1714\u201325.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"589_CR51","doi-asserted-by":"publisher","first-page":"e230813","DOI":"10.1001\/jamanetworkopen.2023.0813","volume":"6","author":"JJ Nunez","year":"2023","unstructured":"Nunez JJ, Leung B, Ho C, Bates AT, Ng RT. Predicting the Survival of Patients With Cancer From Their Initial Oncology Consultation Document Using Natural Language Processing. JAMA Netw Open. 2023;6:e230813.","journal-title":"JAMA Netw Open"}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-026-00589-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-026-00589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-026-00589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:48:53Z","timestamp":1792536533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-026-00589-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s13040-026-00589-3","relation":{},"ISSN":["1756-0381"],"issn-type":[{"value":"1756-0381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There is no ethics declaration as all the patient data were obtained from online databases.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"82"}}